{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:11:58Z","timestamp":1792685518630,"version":"4.5.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.clinthera.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T21:37:54Z","timestamp":1775684274000},"page":"449-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Artificial Intelligence in Personalized Breast Cancer Drug Safety: From Preclinical Toxicology to Clinical Risk Management"],"prefix":"10.1016","volume":"48","author":[{"given":"Jayashree","family":"Venugopal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surabhi","family":"Panneerselvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afroz","family":"Patan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Panneerselvam","family":"Theivendren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.03.002_bib0001","doi-asserted-by":"crossref","first-page":"10023","DOI":"10.1007\/s11033-022-07571-2","article-title":"Breast cancer in the era of precision medicine","volume":"49","author":"Sarhangi","year":"2022","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0002","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/978-1-0716-0904-0_5","article-title":"Diagnosis and treatment of breast cancer in the precision medicine era","volume":"2204","author":"Yan","year":"2020","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0003","series-title":"Drug Repurposing: Molecular Aspects and Therapeutic Applications","first-page":"167","article-title":"The future perspectives of drug repurposing and treatment for the drug resistant breast cancer","author":"Theivendren","year":"2022"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0004","doi-asserted-by":"crossref","first-page":"235","DOI":"10.14744\/ejmo.2024.45903","article-title":"The application of artificial intelligence in breast cancer","volume":"8","author":"Nafissi","year":"2024","journal-title":"Eurasian J Med Oncol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0005","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s12668-025-01980-w","article-title":"Artificial intelligence-assisted design of nanomedicines for breast cancer diagnosis and therapy: advances, challenges, and future directions","volume":"15","author":"Shirzad","year":"2025","journal-title":"BioNanoScience"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0006","doi-asserted-by":"crossref","DOI":"10.1088\/2057-1976\/aac9ec","article-title":"Preparation of liposomes encapsulated epirubicin-gold nanoparticles for tumor specific delivery and release","volume":"4","author":"Kunjiappan","year":"2018","journal-title":"Biomed Phys Eng Express"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0007","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1002\/ddr.22115","article-title":"Artificial intelligence revolutionizing drug development: exploring opportunities and challenges","volume":"84","author":"Tiwari","year":"2023","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0008","doi-asserted-by":"crossref","first-page":"bbaf533","DOI":"10.1093\/bib\/bbaf533","article-title":"Computational toxicology in drug discovery: applications of artificial intelligence in ADMET and toxicity prediction","volume":"26","author":"Zhang","year":"2025","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0009","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1002\/ddr.21758","article-title":"Surface receptor-mediated targeted drug delivery systems for enhanced cancer treatment: a state-of-the-art review","volume":"82","author":"Kunjiappan","year":"2021","journal-title":"Drug Dev Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0010","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3390\/cimb47060470","article-title":"Integrating artificial intelligence in next-generation sequencing: advances, challenges, and future directions","volume":"47","author":"Athanasopoulou","year":"2025","journal-title":"Curr Issues Mol Biol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0011","doi-asserted-by":"crossref","first-page":"3148","DOI":"10.3390\/cancers13133148","article-title":"Integrative analysis of next-generation sequencing for next-generation cancer research toward artificial intelligence","volume":"13","author":"Park","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.drudis.2025.104360","article-title":"Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing","volume":"30","author":"Gangwal","year":"2025","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0013","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.toxlet.2025.07.1417","article-title":"Use of artificial intelligence in animal experimentation: a review","volume":"411","author":"Gon\u00e7alves","year":"2025","journal-title":"Toxicol Lett"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2024.127526","article-title":"Advancements in breast cancer therapy: the promise of copper nanoparticles","volume":"86","author":"Surya","year":"2024","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0015","series-title":"Bioinformatics Tools for Pharmaceutical Drug Product Development","first-page":"255","article-title":"AI, ML and other bioinformatics tools for preclinical and clinical development of drug products","author":"Khadela","year":"2023"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0016","doi-asserted-by":"crossref","first-page":"2691","DOI":"10.2147\/DDDT.S424991","article-title":"The coming of age of AI\/ML in drug discovery, development, clinical testing, and manufacturing: the FDA perspectives","volume":"17","author":"Niazi","year":"2023","journal-title":"Drug Des Devel Ther."},{"key":"10.1016\/j.clinthera.2026.03.002_bib0017","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.2174\/0113816128357976250122042633","article-title":"Targeting the PI3K pathway: advancements and achievements in breast cancer therapy","volume":"31","author":"Dinesh","year":"2025","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0018","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1002\/cpt.1907","article-title":"From real-world patient data to individualized treatment effects using machine learning: current and future methods to address underlying challenges","volume":"109","author":"Bica","year":"2021","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0019","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1186\/s13063-021-05489-x","article-title":"The role of machine learning in clinical research: transforming the future of evidence generation","volume":"22","author":"Weissler","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.clinthera.2026.03.002_sbref0020","first-page":"297","article-title":"Success stories: impactful applications of cancer biomarkers","author":"Theivendren","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0021","doi-asserted-by":"crossref","DOI":"10.34172\/bi.30984","article-title":"The role of artificial intelligence in enhancing breast cancer screening and diagnosis: a review of current advances","volume":"15","author":"Firuzpour","year":"2025","journal-title":"BioImpacts"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0022","series-title":"Adoption Implications in Healthcare Contexts.","article-title":"AI-Driven Decision Support Systems for Early Breast Cancer Detection","author":"Tsoupras","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0023","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbior.2025.101102","article-title":"In-depth review of breast cancer and inflammation pre-and post-treatment strategies with conventional and novel steroid agents","volume":"97","author":"Theivendren","year":"2025","journal-title":"Adv Biol Regul"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e05948","article-title":"Drug combination and repurposing for cancer therapy: the example of breast cancer","volume":"7","author":"Correia","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0025","first-page":"721","article-title":"Breast cancer: an overview of current therapeutic strategies, challenge, and perspectives","volume":"15","author":"Wang","year":"2023","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.clinthera.2026.03.002_sbref0026","first-page":"127","article-title":"Clinical trials of materials for medical applications\u2014materials testing for toxicity, efficacy, disease treatment, and diagnosis in humans (clinical trial phase I, phase II, phase III, and phase IV)","author":"Iftikhar","year":"2023"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0027","series-title":"Advances in Pharmaceutical Product Development","first-page":"423","article-title":"Pre-clinical and clinical studies, pharmacovigilance, pharmacogenomics, and commercialization of pharmaceutical products","author":"Joshi","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0028","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2025.217821","article-title":"Role of artificial intelligence in cancer drug discovery and development","volume":"627","author":"Sarvepalli","year":"2025","journal-title":"Cancer Lett"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0029","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2147\/JMDH.S410301","article-title":"Machine learning and AI in cancer prognosis, prediction, and treatment selection: a critical approach","volume":"16","author":"Zhang","year":"2023","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0030","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s44339-024-00010-w","article-title":"Integrated approaches for immunotoxicity risk assessment: challenges and future directions","volume":"1","author":"Chandrasekar","year":"2024","journal-title":"Discov Toxicol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0031","doi-asserted-by":"crossref","first-page":"e1804","DOI":"10.1002\/wnan.1804","article-title":"Immunotoxicity of nanomaterials in health and disease: current challenges and emerging approaches for identifying immune modifiers in susceptible populations","volume":"14","author":"Hofer","year":"2022","journal-title":"Wiley Interdiscip Rev Nanomed Nanobiotechnol"},{"issue":"23","key":"10.1016\/j.clinthera.2026.03.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1088\/1361-6528\/add6ae","article-title":"Emerging therapeutic strategies and opportunities in targeting protein pathways for breast cancer treatment: a critical review","volume":"36","author":"Theivendren","year":"2025","journal-title":"Nanotechnology"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0033","series-title":"Forensic Intelligence and Deep Learning Solutions in Crime Investigation","first-page":"125","article-title":"Exploring artificial intelligence (AI) in forensic pathology and autopsy analysis","author":"Malviya","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0034","article-title":"Strategies for the drug development of cancer therapeutics","volume":"16","author":"Liu","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0035","series-title":"Preclinical Cancer Models for Translational Research and Drug Development","first-page":"153","article-title":"In silico strategies for cancer model development and anticancer drug testing","author":"Shyam","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0036","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.2174\/1871520619666190702145609","article-title":"Design, in silico modelling, and functionality theory of novel folate receptor targeted rutin encapsulated folic acid conjugated keratin nanoparticles for effective cancer treatment","volume":"19","author":"Kunjiappan","year":"2019","journal-title":"Anticancer Agents Med Chem"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0037","doi-asserted-by":"crossref","first-page":"8814","DOI":"10.3390\/molecules27248814","article-title":"Cytotoxic potential of bioactive compounds from Aspergillus flavus, an endophytic fungus isolated from Cynodon dactylon, against breast cancer: experimental and computational approach","volume":"27","author":"Kalimuthu","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0038","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41598-023-49839-y","article-title":"Optimization of ultrasound-aided extraction of bioactive ingredients from Vitis vinifera seeds using RSM and ANFIS modeling with machine learning algorithm","volume":"14","author":"Kunjiappan","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0039","doi-asserted-by":"crossref","first-page":"9","DOI":"10.3390\/ddc4010009","article-title":"A review on revolutionizing healthcare technologies with AI and ML applications in pharmaceutical sciences","volume":"4","author":"Kandhare","year":"2025","journal-title":"Drugs Drug Candidates"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0040","doi-asserted-by":"crossref","first-page":"115","DOI":"10.22270\/jddt.v15i10.7394","article-title":"Redefining preclinical research paradigms: AI-driven drug discovery as a transformative approach to accelerate innovation, improve predictive accuracy, and reduce reliance on animal testing","volume":"15","author":"Nagpure","year":"2025","journal-title":"J Drug Deliv Ther"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0041","doi-asserted-by":"crossref","DOI":"10.3390\/ijms262110744","article-title":"Computer-aided drug design across breast cancer subtypes: methods, applications and translational outlook","volume":"26","author":"Tian","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0042","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1021\/acsptsci.2c00212","article-title":"Ranking breast cancer drugs and biomarkers identification using machine learning and pharmacogenomics","volume":"6","author":"Mehmood","year":"2023","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0043","article-title":"Integration of transcriptomics and machine learning for insights into breast cancer: exploring lipid metabolism and immune interactions","volume":"15","author":"Chen","year":"2024","journal-title":"Front Immunol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0044","first-page":"4","article-title":"The application of artificial intelligence-based tools in the management of hepatocellular carcinoma: current status and future perspectives","volume":"11","author":"Celsa","year":"2025","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0045","doi-asserted-by":"crossref","DOI":"10.2174\/0113816128364693250117060342","article-title":"Leveraging AI and natural compounds: innovative approaches in the diagnosis and treatment of hepatocellular carcinoma","author":"Suhail","year":"2025","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0046","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1158\/0008-5472.CAN-22-1277","article-title":"Case studies for overcoming challenges in using big data in cancer","volume":"83","author":"Sweeney","year":"2023","journal-title":"Cancer Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0047","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jama.2020.1039","article-title":"Randomized clinical trials of artificial intelligence","volume":"323","author":"Angus","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0048","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2021.635524","article-title":"Personalised, rational, efficacy-driven cancer drug dosing via an artificial intelligence SystEm (PRECISE): a protocol for the PRECISE CURATE.AI pilot clinical trial","volume":"3","author":"Tan","year":"2021","journal-title":"Front Digit Health"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0049","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s43441-019-00030-4","article-title":"Improving clinical trial participant prescreening with artificial intelligence (AI): a comparison of the results of AI-assisted vs standard methods in 3 oncology trials","volume":"54","author":"Calaprice-Whitty","year":"2020","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0050","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1038\/s41586-021-03430-5","article-title":"Evaluating eligibility criteria of oncology trials using real-world data and AI","volume":"592","author":"Liu","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0051","doi-asserted-by":"crossref","DOI":"10.2174\/0115748871359356250523033831","article-title":"A review of software in clinical trials: FDA regulatory frameworks and addressing challenges","author":"Dixit","year":"2025","journal-title":"Rev Recent Clin Trials"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0052","doi-asserted-by":"crossref","first-page":"701","DOI":"10.3390\/healthcare13070701","article-title":"Bridging the gap: from AI success in clinical trials to real-world healthcare implementation\u2014a narrative review","volume":"13","author":"El Arab","year":"2025","journal-title":"Healthcare (Basel)"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0053","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s13148-022-01263-1","article-title":"Ethical implications of epigenetics in the era of personalized medicine","volume":"14","author":"Santal\u00f3","year":"2022","journal-title":"Clin Epigenetics"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0054","series-title":"Preventing and Treating Cancer through Genetic Testing, Research, and Pharmacogenetics: Ethical and Legal Challenges","author":"Stasi","year":"2023"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0055","doi-asserted-by":"crossref","first-page":"e896","DOI":"10.1097\/PR9.0000000000000896","article-title":"Patient phenotyping in clinical trials of chronic pain treatments: IMMPACT recommendations","volume":"6","author":"Edwards","year":"2021","journal-title":"Pain Rep"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0056","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphar.2020.00420","article-title":"Precision dosing priority criteria: drug, disease, and patient population variables","volume":"11","author":"Tyson","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0057","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12943-025-02321-x","article-title":"Emerging artificial intelligence-driven precision therapies in tumor drug resistance: recent advances, opportunities, and challenges","volume":"24","author":"Mao","year":"2025","journal-title":"Mol Cancer"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0058","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ipha.2024.08.005","article-title":"AI's role in revolutionizing personalized medicine by reshaping pharmacogenomics and drug therapy","volume":"2","author":"Taherdoost","year":"2024","journal-title":"Intelligent Pharmacy"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0059","doi-asserted-by":"crossref","first-page":"125","DOI":"10.12923\/cipms-2025-0020","article-title":"Harnessing machine learning for predictive pharmacokinetics: revolutionizing drug development and personalized medicine","volume":"38","author":"Dudarski","year":"2025","journal-title":"Curr Issues Pharm Med Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0060","doi-asserted-by":"crossref","first-page":"bbaf329","DOI":"10.1093\/bib\/bbaf329","article-title":"Advancing genome-based precision medicine: a review on machine learning applications for rare genetic disorders","volume":"26","author":"Abbas","year":"2025","journal-title":"Brief Bioinform"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0061","first-page":"371","article-title":"Bioinformatics applications in chronic diseases: a comprehensive review of genomic, transcriptomics, proteomic, metabolomics, and machine learning approaches","volume":"52","author":"Ogunjobi","year":"2024","journal-title":"Medinformatics"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0062","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.medj.2021.04.006","article-title":"Machine learning in clinical decision making","volume":"2","author":"Adlung","year":"2021","journal-title":"Med"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0063","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s42234-020-00050-8","article-title":"Machine learning to assist clinical decision-making during the COVID-19 pandemic","volume":"6","author":"Debnath","year":"2020","journal-title":"Bioelectron Med"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0064","series-title":"Intelligent Data Analytics for Bioinformatics and Biomedical Systems","first-page":"291","article-title":"Wearable devices and health monitoring: big data and AI for remote patient care","author":"Kanakaprabha","year":"2024"},{"issue":"5","key":"10.1016\/j.clinthera.2026.03.002_bib0065","first-page":"1","article-title":"Real-time predictive health monitoring using AI-driven wearable sensors: Enhancing early detection and personalized interventions in chronic disease management","volume":"6","author":"Khan","year":"2024","journal-title":"Int J Multidiscip Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0066","doi-asserted-by":"crossref","DOI":"10.2196\/77204","article-title":"Layperson-friendly AI translation of medical documents to improve doctor\u2013patient communication: protocols for the AI-INFOCARE and AI-MEDTALK randomized controlled trials","volume":"14","author":"Hasani","year":"2025","journal-title":"JMIR Res Protoc"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0067","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S2213-2600(24)00327-8","article-title":"Augmenting clinical trials in asthma through digital technology, decentralised designs, and person-centric endpoints: opportunities and challenges","volume":"13","author":"van Boven","year":"2025","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0068","doi-asserted-by":"crossref","first-page":"108","DOI":"10.9734\/jocamr\/2024\/v25i7552","article-title":"Post-market surveillance of medical devices using AI","volume":"25","author":"Khinvasara","year":"2024","journal-title":"J Complement Altern Med Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0069","doi-asserted-by":"crossref","DOI":"10.1016\/j.artmed.2023.102701","article-title":"Natural language processing with machine learning methods to analyze unstructured patient-reported outcomes derived from electronic health records: a systematic review","volume":"146","author":"Sim","year":"2023","journal-title":"Artif Intell Med"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0140-6736(22)01841-4","article-title":"A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study","volume":"401","author":"Swen","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0071","doi-asserted-by":"crossref","DOI":"10.1016\/j.ipm.2019.102131","article-title":"Adverse drug event detection and extraction from open data: a deep learning approach","volume":"57","author":"Fan","year":"2020","journal-title":"Inf Process Manage"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0072","doi-asserted-by":"crossref","DOI":"10.1016\/j.dss.2022.113800","article-title":"Towards risk-aware artificial intelligence and machine learning systems: an overview","volume":"159","author":"Zhang","year":"2022","journal-title":"Decis Support Syst"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0073","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1080\/17410541.2025.2494980","article-title":"Global harmonization in advanced therapeutics: balancing innovation, safety, and access","volume":"22","author":"Dahiya","year":"2025","journal-title":"Per Med"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0074","doi-asserted-by":"crossref","first-page":"350","DOI":"10.30574\/gscbps.2022.18.2.0027","article-title":"Harnessing predictive analytics for proactive drug safety monitoring: trends in regulatory reporting, recalls and adverse event detection","volume":"18","author":"Kadiri","year":"2022","journal-title":"GSC Biol Pharm Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0075","series-title":"Technology for Drug Safety: Current Status and Future Developments","author":"Al-Worafi","year":"2023"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0076","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/emre.12573","article-title":"Fast and high-quality decision-making: the role of behavioral integration","volume":"20","author":"Shepherd","year":"2023","journal-title":"Eur Manag Rev"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0077","doi-asserted-by":"crossref","first-page":"15","DOI":"10.17691\/stm2022.14.5.02","article-title":"Methodology for conducting post-marketing surveillance of software as a medical device based on artificial intelligence technologies","volume":"14","author":"Zinchenko","year":"2022","journal-title":"Sovrem Tekhnologii Med"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0078","doi-asserted-by":"crossref","first-page":"94583","DOI":"10.1109\/ACCESS.2022.3201878","article-title":"Systematic review on ai-blockchain based e-healthcare records management systems","volume":"10","author":"Haddad","year":"2022","journal-title":"IEEE Access"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0079","doi-asserted-by":"crossref","unstructured":"Majekodunmi E.A. Strengthening Drug Safety and Public Health Surveillance in the United States: The Role of Artificial Intelligence in Pharmacovigilance. Available at SSRN 5181179. 2025.","DOI":"10.2139\/ssrn.5181179"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0080","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1080\/17425255.2024.2356162","article-title":"Recent progress in machine learning approaches for predicting carcinogenicity in drug development","volume":"20","author":"Le","year":"2024","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0081","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s10916-025-02182-3","article-title":"Mlg2net: molecular global graph network for drug response prediction in lung cancer cell lines","volume":"49","author":"Tran","year":"2025","journal-title":"J Med Syst"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0082","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1055\/a-2181-0813","article-title":"A review of PARP-1 inhibitors: assessing emerging prospects and tailoring therapeutic strategies","volume":"73","author":"Ramesh","year":"2023","journal-title":"Drug Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0083","article-title":"Utilization of Camellia sinensis as a STAT inhibitor in the management and prevention of breast cancer: a review","volume":"9","author":"Theivendren","year":"2025","journal-title":"Pharmacol Res Nat Prod"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0084","first-page":"927","article-title":"Exploring AI approaches for breast cancer detection and diagnosis: a review article","volume":"17","author":"Ali","year":"2025","journal-title":"Breast Cancer (Dove Med Press)"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0085","article-title":"Towards secure and trusted AI in healthcare: a systematic review of emerging innovations and ethical challenges","volume":"195","author":"Khan","year":"2025","journal-title":"Int J Med Inform"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0086","doi-asserted-by":"crossref","first-page":"7082","DOI":"10.3390\/app13127082","article-title":"Re-thinking data strategy and integration for artificial intelligence: concepts, opportunities, and challenges","volume":"13","author":"Aldoseri","year":"2023","journal-title":"Appl Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0087","doi-asserted-by":"crossref","DOI":"10.2196\/62941","article-title":"Challenges in implementing artificial intelligence in breast cancer screening programs: systematic review and framework for safe adoption","volume":"27","author":"Goh","year":"2025","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0088","doi-asserted-by":"crossref","first-page":"437","DOI":"10.3390\/cancers12020437","article-title":"FDA and EMA approvals of new breast cancer drugs\u2014a comparative regulatory analysis","volume":"12","author":"Leo","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0089","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/d41573-019-00201-w","article-title":"Breast cancer drug approvals by the US FDA from 1949 to 2018","volume":"19","author":"Leo","year":"2020","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0090","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.3390\/cancers13205198","article-title":"Breast cancer drug approvals issued by EMA: a review of clinical trials","volume":"13","author":"Duranti","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0091","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1158\/1078-0432.CCR-21-2600","article-title":"U.S. FDA drug approvals for breast cancer: a decade in review","volume":"28","author":"Arora","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0092","series-title":"Plant-Derived Anticancer Drugs","first-page":"29","article-title":"United States and European Union Regulations: approved treatment modalities for managing cancer","author":"Biharee","year":"2025"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0093","first-page":"37","article-title":"The synergy of artificial intelligence and machine learning in revolutionizing pharmaceutical regulatory affairs","volume":"6","author":"Gude","year":"2024","journal-title":"Transl Regul Sci"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0094","article-title":"From blackbox to explainable AI in healthcare: existing tools and case studies","volume":"2022","author":"Srinivasu","year":"2022","journal-title":"Mob Inf Syst"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0095","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s12559-023-10179-8","article-title":"Interpreting black-box models: a review on explainable artificial intelligence","volume":"16","author":"Hassija","year":"2024","journal-title":"Cogn Comput"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0096","unstructured":"Das A, Rad P. Opportunities and challenges in explainable artificial intelligence (xai): a survey. 2020 Jun 23. [Epub ahead of print]"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0097","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1007\/s10462-021-10088-y","article-title":"Explainable artificial intelligence: a comprehensive review","volume":"55","author":"Minh","year":"2022","journal-title":"Artif Intell Rev"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0098","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejrad.2024.111393","article-title":"Artificial intelligence and explanation: how, why, and when to explain black boxes","volume":"173","author":"Marcus","year":"2024","journal-title":"Eur J Radiol"},{"issue":"3","key":"10.1016\/j.clinthera.2026.03.002_bib0099","first-page":"144","article-title":"Multi-objective Symbolic Regression for Clinician-in-the-loop Machine Learning algorithms","volume":"34","author":"Ferrari","year":"2024","journal-title":"Europ J Public Health"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0100","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1186\/s12874-025-02649-4","article-title":"3D IntelliGenes: AI\/ML application using multi-omics data for biomarker discovery and disease prediction with multi-dimensional visualization","volume":"25","author":"Narayanan","year":"2025","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0101","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/d41573-021-00018-6","article-title":"The breast cancer drug market","volume":"20","author":"Wilcock","year":"2021","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0102","doi-asserted-by":"crossref","first-page":"645","DOI":"10.3390\/info14120645","article-title":"The dilemma of rapid AI advancements: striking a balance between innovation and regulation by pursuing risk-aware value creation","volume":"14","author":"Ricciardi Celsi","year":"2023","journal-title":"Information"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0103","doi-asserted-by":"crossref","first-page":"405","DOI":"10.4048\/jbc.2023.26.e45","article-title":"Artificial intelligence in breast cancer diagnosis and personalized medicine","volume":"26","author":"Ahn","year":"2023","journal-title":"J Breast Cancer"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0104","doi-asserted-by":"crossref","DOI":"10.1002\/qub2.70002","article-title":"Revolutionizing multi-omics analysis with artificial intelligence and data processing","volume":"13","author":"Yetgin","year":"2025","journal-title":"Quant Biol"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0105","first-page":"245","article-title":"Advancements in natural language processing for automated phenotyping and predictive analytics in oncology EHRS","volume":"8","author":"Kothinti","year":"2021","journal-title":"Iconic Res Eng J"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0106","doi-asserted-by":"crossref","first-page":"21","DOI":"10.55248\/gengpi.5.0224.0421","article-title":"AI-driven precision oncology: predictive biomarker discovery and personalized treatment optimization using genomic data","volume":"1","author":"Kumar","year":"2024","journal-title":"Int J Adv Res Publ Rev"},{"key":"10.1016\/j.clinthera.2026.03.002_bib0107","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-025-00758-2","article-title":"Integrating artificial intelligence in drug discovery and early drug development: a transformative approach","volume":"13","author":"Ocana","year":"2025","journal-title":"Biomark Res"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826000640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:33:22Z","timestamp":1782376402000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826000640"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":107,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S0149291826000640"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Artificial Intelligence in Personalized Breast Cancer Drug Safety: From Preclinical Toxicology to Clinical Risk Management","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}